In situ enzyme‐triggered peptide self‐assembly strategies have been applied to selectively modify cell membranes or selectively degrade programmed cell death ligand 1 (PD‐L1) in tumor cells.5, 15. This evidence concerns the gene CD274 and neoplasm.